First Annual Global Clinical Trials Update
Автор: The International Alliance of ALS/MND Associations
Загружено: 2022-11-09
Просмотров: 435
English and Spanish captions available with this video.
Para subtítulos en español, ve a configuración en el menú del video, selecciona subtítulos y luego español.
This webinar will provide information on ALS/MND treatments currently in Phase 3 Clinical Trials. We will hear directly about timelines, where the sites are, other programs offered, and who to contact if more information is needed. Moderated by Gethin Thomas, Executive Director, Research – MND Australia, and Dr. Thanuja Dharmadasa, Senior Clinical Research Fellow at The Royal Melbourne Hospital and The Florey Institute of Neuroscience and Mental Health in Victoria, Australia.
We will hear from AB Science, Amylyx, Biogen, Clene Nanomedicine, Cytokinetics, Ferrer, Ionis, and Mitsubishi Tanabe Pharma!
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
